Characterized by their hallmark cytokines, IL-10 and TGF-β, which can effectively suppress tumor-specific T cell activation, Tregs are attracted to the local tumor environment by soluble mediators, such as CCL22 or CCL2 produced by glioblastoma cells (17–19). Here, IL10 is linked to neoplasm.